Palle Mark Christensen

Summary

Affiliation: University of Southern Denmark
Country: Denmark

Publications

  1. ncbi request reprint Expressing effects of osteoporosis interventions in terms of postponing of fractures
    Palle Mark Christensen
    Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Winsloewparken 19, 5000 Odense C, Denmark
    Eur J Clin Pharmacol 58:629-33. 2002
  2. ncbi request reprint A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture
    Palle Mark Christensen
    Research Unit of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Winsloewparken 19, 5000 Odense C, Denmark
    Clin Ther 25:2575-85. 2003
  3. ncbi request reprint [Evaluation of the effects of treatment of osteoporosis]
    Palle Mark Christensen
    Syddansk Universitet, Forskningsenheden for klinisk farmakologi
    Ugeskr Laeger 167:1031-3. 2005
  4. ncbi request reprint Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women
    Palle Mark Christensen
    Research Unit of Clinical Pharmacology, University of Southern Denmark, 5000 Odense, Denmark
    Basic Clin Pharmacol Toxicol 96:387-96. 2005
  5. ncbi request reprint Number-needed-to-treat (NNT)--needs treatment with care
    Palle Mark Christensen
    Research Unit of Clinical Pharmacology and Research Unit for General Practice, University of Southern Denmark, Odense, Denmark
    Basic Clin Pharmacol Toxicol 99:12-6. 2006
  6. ncbi request reprint Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis
    Kim T Brixen
    Department of Endocrinology, Odense University Hospital, Odense, Denmark
    Basic Clin Pharmacol Toxicol 94:260-70. 2004
  7. ncbi request reprint [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review]
    Palle Mark Christensen
    Odense Universitetshospital, Endokrinologisk Afdeling, Syddansk Universitet, Klinisk Farmakologi og Sundhedsøkonomi, DSI Institut for Sundhedsvaesen, København
    Ugeskr Laeger 164:1339-45. 2002
  8. ncbi request reprint [Compliance with the treatment of osteoporosis with diphosphonates. A questionnaire among postmenopausal women]
    Rasmus Wulff
    Odense Universitetshospital, Endokrinologisk Afdeling M, Sektion for Klinisk Farmakologi
    Ugeskr Laeger 166:49-53. 2004
  9. ncbi request reprint [Breakthrough in the treatment of osteoporosis]
    Kim T Brixen
    Ugeskr Laeger 166:2649. 2004

Detail Information

Publications9

  1. ncbi request reprint Expressing effects of osteoporosis interventions in terms of postponing of fractures
    Palle Mark Christensen
    Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Winsloewparken 19, 5000 Odense C, Denmark
    Eur J Clin Pharmacol 58:629-33. 2002
    ..To estimate the effect from an osteoporosis intervention in terms of postponement of hip fractures...
  2. ncbi request reprint A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture
    Palle Mark Christensen
    Research Unit of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Winsloewparken 19, 5000 Odense C, Denmark
    Clin Ther 25:2575-85. 2003
    ..An alternative to such risk-based measures is postponement of an adverse outcome (eg, hip fracture in the case of osteoporosis)...
  3. ncbi request reprint [Evaluation of the effects of treatment of osteoporosis]
    Palle Mark Christensen
    Syddansk Universitet, Forskningsenheden for klinisk farmakologi
    Ugeskr Laeger 167:1031-3. 2005
  4. ncbi request reprint Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women
    Palle Mark Christensen
    Research Unit of Clinical Pharmacology, University of Southern Denmark, 5000 Odense, Denmark
    Basic Clin Pharmacol Toxicol 96:387-96. 2005
    ..In conclusion, the use of alendronate compares well with other well established therapies in terms of cost-effectiveness in older women with high risk of fracture...
  5. ncbi request reprint Number-needed-to-treat (NNT)--needs treatment with care
    Palle Mark Christensen
    Research Unit of Clinical Pharmacology and Research Unit for General Practice, University of Southern Denmark, Odense, Denmark
    Basic Clin Pharmacol Toxicol 99:12-6. 2006
    ..Finally, empirical studies indicate that lay people and doctors misunderstand NNT. We recommend that NNT be used with considerable care. There is probably no single effect measure that is able to convey all necessary information...
  6. ncbi request reprint Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis
    Kim T Brixen
    Department of Endocrinology, Odense University Hospital, Odense, Denmark
    Basic Clin Pharmacol Toxicol 94:260-70. 2004
    ..Other parathyroid hormone analogues are being investigated in clinical trials and the development of non-peptide, small molecules targeted at the parathyroid hormone receptor may be envisaged...
  7. ncbi request reprint [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review]
    Palle Mark Christensen
    Odense Universitetshospital, Endokrinologisk Afdeling, Syddansk Universitet, Klinisk Farmakologi og Sundhedsøkonomi, DSI Institut for Sundhedsvaesen, København
    Ugeskr Laeger 164:1339-45. 2002
    ..The aim of this paper was to evaluate existing literature by applying cost-effectiveness (CEA) and cost-utility analyses (CUA) to pharmacological treatment of osteoporosis...
  8. ncbi request reprint [Compliance with the treatment of osteoporosis with diphosphonates. A questionnaire among postmenopausal women]
    Rasmus Wulff
    Odense Universitetshospital, Endokrinologisk Afdeling M, Sektion for Klinisk Farmakologi
    Ugeskr Laeger 166:49-53. 2004
  9. ncbi request reprint [Breakthrough in the treatment of osteoporosis]
    Kim T Brixen
    Ugeskr Laeger 166:2649. 2004